MolForge is reinventing drug discovery with AI. Here you'll find our latest news, brand assets, and media resources.
Press releases and company announcements
IP Radar combines multi-agent AI with access to 100M+ global patents, enabling pharmaceutical researchers to identify white-space opportunities and navigate patent landscapes in minutes instead of months.
Read MoreThe latest version of IP Radar introduces real-time streaming patent analysis, multi-agent orchestration powered by MolForge AI AI, and interactive claim mapping for complex patent portfolios.
Read MoreAggregating data from PubChem, ChEMBL, and proprietary sources, MolForge now offers the largest AI-ready molecular dataset purpose-built for predictive modeling and virtual screening workflows.
Read MoreResearchers worldwide can now design, edit, and export molecules in a browser-based 3D environment. The Molecule Builder supports SDF, PDB, XYZ, and JSON-LD formats with full PubChem integration.
Read MoreKey figures and milestones
Logos, colors, and guidelines for media use
#00d4ff
#7c3aed
#0a0e27
135deg
Please use our assets according to our brand guidelines. Do not alter the logo, change its colors, or use it in a way that implies endorsement without written permission.
Get in touch with our communications team
Stay updated on the latest from MolForge
MolForge in the press
Interested in covering MolForge? Reach out to [email protected] for interviews, demos, and additional materials.